Cancer cells could shape its microenvironment into a pro-tumor type through the modulation on infiltrated immune cells12, and we wondered whether dectin-1 could participate in such process and become a potential prognostic marker for RCC patients. The gene discussed is CLEC7A; the disease is neoplasm.